LAUREN HORNSBY: Open Payments
NPI 1972932036 · CARROLLTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 27 payments from 8 companies in 2025. Trend: 2023 $232 · 2024 $295 · 2025 $536
Food & beverage: $457Education: $78
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $101 |
| Lundbeck LLC | 4 | $82 |
| Teva Pharmaceuticals USA, Inc. | 1 | $78 |
| Supernus Pharmaceuticals, Inc. | 3 | $50 |
| ABBVIE INC. | 3 | $46 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
| Alkermes, Inc. | 2 | $29 |
Products named: Auvelity, CAPLYTA, REXULTI, Qelbree, VRAYLAR, FANAPT, ARISTADA.
Industry payments across GA — which companies pay providers there.
